Trial Profile
Valacyclovir+Temovate Gel for the Episodic Treatment of Herpes Labialis: A Patient-Initiated Double-Blind, Placebo-Controlled Study, Randomized Study.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 21 Aug 2023
Price :
$35
*
At a glance
- Drugs Clobetasol (Primary) ; Valaciclovir (Primary)
- Indications Herpes labialis
- Focus Therapeutic Use
- 14 May 2007 The expected completion date for this trial is now 1 May 2007.
- 11 Nov 2006 New trial record.